[go: up one dir, main page]

MY122755A - Polymorphs of telmisartan - Google Patents

Polymorphs of telmisartan

Info

Publication number
MY122755A
MY122755A MYPI20000130A MYPI20000130A MY122755A MY 122755 A MY122755 A MY 122755A MY PI20000130 A MYPI20000130 A MY PI20000130A MY PI20000130 A MYPI20000130 A MY PI20000130A MY 122755 A MY122755 A MY 122755A
Authority
MY
Malaysia
Prior art keywords
polymorphs
telmisartan
preparingtelmisartan
ylmethy
methylbenzimidazol
Prior art date
Application number
MYPI20000130A
Inventor
Heinrich Schneider Dr
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MY122755A publication Critical patent/MY122755A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

THE INVENTION RELATES TO POLYMORPHS OF 4' - [2-N-PROPYL-4-METHYL-6- (1-METHYLBENZIMIDAZOL-2-YL) BENZIMIDAZOL-1-YLMETHY] BIPHENYL-2-CARBOXYLIC ACID (INN: TELMISARTAN), PARTICULARLY POLYMORPHIC FROM B, MIXTURES OF THE POLYMORPHS, PROCESSES FOR PREPARINGTELMISARTAN CONTAINING FORM B AND THE USE THEREOF FOR PREPARING A PHARMACEUTICAL COMPOSITION.
MYPI20000130A 1999-01-19 2000-01-17 Polymorphs of telmisartan MY122755A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19901921A DE19901921C2 (en) 1999-01-19 1999-01-19 Polymorphs of telmisartan, process for their preparation and their use in the manufacture of a medicament

Publications (1)

Publication Number Publication Date
MY122755A true MY122755A (en) 2006-05-31

Family

ID=7894715

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20000130A MY122755A (en) 1999-01-19 2000-01-17 Polymorphs of telmisartan

Country Status (36)

Country Link
EP (1) EP1144386B1 (en)
JP (1) JP4700813B2 (en)
KR (1) KR100658959B1 (en)
CN (1) CN1144790C (en)
AR (1) AR035475A1 (en)
AT (1) ATE252564T1 (en)
AU (1) AU765081B2 (en)
BG (1) BG65027B1 (en)
BR (1) BR0007584A (en)
CA (1) CA2352436C (en)
CO (1) CO5150238A1 (en)
CZ (1) CZ297412B6 (en)
DE (2) DE19901921C2 (en)
DK (1) DK1144386T3 (en)
EA (1) EA003065B1 (en)
EE (1) EE04344B1 (en)
ES (1) ES2208265T3 (en)
HK (1) HK1041485B (en)
HR (1) HRP20010514B1 (en)
HU (1) HU227401B1 (en)
IL (2) IL143634A0 (en)
MY (1) MY122755A (en)
NO (1) NO319823B1 (en)
NZ (1) NZ513528A (en)
PE (1) PE20001362A1 (en)
PL (1) PL211829B1 (en)
PT (1) PT1144386E (en)
RS (1) RS50044B (en)
SA (1) SA99200838B1 (en)
SK (1) SK285429B6 (en)
TR (1) TR200102074T2 (en)
TW (1) TWI280241B (en)
UA (1) UA56358C2 (en)
UY (1) UY25980A1 (en)
WO (1) WO2000043370A1 (en)
ZA (1) ZA200104771B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153737A1 (en) * 2001-10-31 2003-05-28 Boehringer Ingelheim Pharma Crystalline sodium salt of telmisartan, process for its preparation and its use for the manufacture of a medicament
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
AU2002242676B2 (en) * 2002-01-16 2008-05-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
DE10314702A1 (en) 2003-03-31 2004-10-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Process for the preparation of telmisartan
GB2414019A (en) * 2004-05-11 2005-11-16 Cipla Ltd One-step preparation of telmisartan by condensation and hydrolysis
CN101039917A (en) 2004-10-15 2007-09-19 特瓦制药工业有限公司 Process for preparing telmisartan
US7943781B2 (en) 2004-10-18 2011-05-17 Dr. Reddy's Laboratories Limited Process for preparing telmisartan
US8637078B2 (en) 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1908469A1 (en) 2006-10-06 2008-04-09 Boehringer Ingelheim Vetmedica Gmbh Angiotensin II receptor antagonist for the treatment of systemic diseases in cats
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
AR076913A1 (en) 2009-05-20 2011-07-20 Boehringer Ingelheim Vetmed TELMISARTAN DRINK PHARMACEUTICAL SOLUTION. METHOD TO PREPARE THE SOLUTION
PL2443094T3 (en) 2009-06-19 2013-08-30 Krka Tovarna Zdravil D D Novo Mesto Process for the preparation of telmisartan
EP2277866A1 (en) 2009-06-22 2011-01-26 Inke, S.A. Process for preparing telmisartan
EP2448575A2 (en) 2009-07-02 2012-05-09 Bilgic Mahmut Pharmaceutical composition increasing solubility and stability
EP2448576A2 (en) 2009-07-02 2012-05-09 Mahmut Bilgic Solubility enhancing pharmaceutical composition
EA025946B1 (en) 2010-10-27 2017-02-28 Крка, Товарна Здравил, Д. Д., Ново Место Multilayer pharmaceutical composition comprising telmisartan and amlodipine
ITMI20102416A1 (en) * 2010-12-27 2012-06-28 Chemelectiva S R L INTERMEDIATE FOR THE PREPARATION OF AN ACTIVE PRINCIPLE AND PROCESS FOR ITS PREPARATION
EP2612658A1 (en) 2012-01-05 2013-07-10 Laboratorios Lesvi, S.L. Pharmaceutical compositions of 4'-[(1,4'dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid and is 6-chloro-3,4-dihydro-2h-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
JP6147546B2 (en) * 2013-04-10 2017-06-14 株式会社トクヤマ Method for producing telmisartan A-type crystals with reduced acetic acid
EP2979691A1 (en) 2014-07-30 2016-02-03 Boehringer Ingelheim International GmbH Oral disintegrating tablet
JP6275596B2 (en) * 2014-09-03 2018-02-07 株式会社トクヤマ Method for producing ammonium salt of telmisartan
JP5871294B1 (en) 2015-02-27 2016-03-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Immediate release oral tablets
KR20170001921A (en) 2015-06-26 2017-01-05 대원제약주식회사 A pharmaceutical composition comprising telmisartan with increased stability and a preparation method thereof
KR20170012703A (en) 2015-07-22 2017-02-03 대원제약주식회사 A pharmaceutical composition comprising telmisartan and a preparation method thereof
EP3463309B1 (en) 2016-05-30 2020-06-17 Boehringer Ingelheim International GmbH Fixed dose combination of telmisartan, hydrochlorothiazide and amlodipine
KR102044223B1 (en) * 2016-09-12 2019-11-13 성균관대학교산학협력단 Solid dispersions comprising Telmisartan and the preparation method thereof
CN106749036B (en) * 2016-12-21 2019-06-21 山东大学 Amorphous telmisartan-pimelic acid co-crystal and preparation method and application thereof
CN106749037B (en) * 2016-12-21 2019-06-21 山东大学 Amorphous telmisartan-glutaric acid co-crystal and preparation method and application thereof
ES2979279T3 (en) 2017-07-07 2024-09-25 Boehringer Ingelheim Vetmedica Gmbh Telmisartan for the prophylaxis or treatment of hypertension in cats
CN109851562A (en) * 2019-01-30 2019-06-07 浙江省食品药品检验研究院 A kind of Telmisartan crystal and preparation method thereof
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
TW202508593A (en) 2023-05-24 2025-03-01 德商百靈佳殷格翰維美迪加股份有限公司 Combination treatment and/or prevention of cardiac diseases in non-human mammals comprising one or more sglt-2 inhibitors and pimobendan and/or telmisartan
AU2024277852A1 (en) 2023-05-24 2025-10-16 Boehringer Ingelheim Vetmedica Gmbh Combination treatment and/or prevention of renal diseases and/or hypertension in non-human mammals comprising one or more sglt-2 inhibitors and telmisartan
US20250195525A1 (en) 2023-12-15 2025-06-19 Boehringer Ingelheim Vetmedica Gmbh Angiotensin ii receptor antagonist for the prevention of systemic diseases in cats

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9210098B (en) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoles, drugs with this compounds, and process for their preparation
US5139114A (en) * 1991-03-18 1992-08-18 Abex Corporation Visible brake block wear indicator

Also Published As

Publication number Publication date
SK10202001A3 (en) 2001-12-03
PE20001362A1 (en) 2000-12-15
UY25980A1 (en) 2001-08-27
YU51101A (en) 2004-05-12
HU227401B1 (en) 2011-05-30
NZ513528A (en) 2003-08-29
HRP20010514A2 (en) 2002-08-31
BG105654A (en) 2002-01-31
BG65027B1 (en) 2006-12-29
AU765081B2 (en) 2003-09-11
EA200100730A1 (en) 2002-02-28
CA2352436A1 (en) 2000-07-27
HUP0105148A3 (en) 2003-01-28
PT1144386E (en) 2004-03-31
AU2288100A (en) 2000-08-07
EP1144386B1 (en) 2003-10-22
HUP0105148A2 (en) 2002-07-29
KR20010101552A (en) 2001-11-14
NO319823B1 (en) 2005-09-19
CA2352436C (en) 2010-03-23
SA99200838B1 (en) 2006-03-06
NO20013560L (en) 2001-09-18
CO5150238A1 (en) 2002-04-29
ATE252564T1 (en) 2003-11-15
DK1144386T3 (en) 2004-01-12
UA56358C2 (en) 2003-05-15
EE200100375A (en) 2002-10-15
IL143634A (en) 2006-10-05
RS50044B (en) 2008-11-28
TR200102074T2 (en) 2001-12-21
KR100658959B1 (en) 2006-12-19
JP4700813B2 (en) 2011-06-15
CN1336920A (en) 2002-02-20
CN1144790C (en) 2004-04-07
IL143634A0 (en) 2002-04-21
HK1041485B (en) 2004-10-08
HRP20010514B1 (en) 2010-01-31
BR0007584A (en) 2001-11-06
CZ20012634A3 (en) 2001-10-17
EE04344B1 (en) 2004-08-16
ZA200104771B (en) 2002-12-02
DE19901921C2 (en) 2001-01-04
JP2002535315A (en) 2002-10-22
ES2208265T3 (en) 2004-06-16
PL211829B1 (en) 2012-06-29
HK1041485A1 (en) 2002-07-12
AR035475A1 (en) 2004-06-02
DE50004150D1 (en) 2003-11-27
SK285429B6 (en) 2007-01-04
EP1144386A1 (en) 2001-10-17
TWI280241B (en) 2007-05-01
CZ297412B6 (en) 2006-12-13
NO20013560D0 (en) 2001-07-18
EA003065B1 (en) 2002-12-26
WO2000043370A1 (en) 2000-07-27
DE19901921A1 (en) 2000-08-03
PL349425A1 (en) 2002-07-29

Similar Documents

Publication Publication Date Title
MY122755A (en) Polymorphs of telmisartan
MY129741A (en) Crystalline form of telmisartan sodium
TW200509914A (en) Pharmaceutical formulation of the telmisartan sodium salt
BR0200782A (en) Compounds for the treatment of ischemia
MXPA04004674A (en) Cannabinoid receptor ligands.
DK1200412T3 (en) Antiproliferative imidazole compounds
WO2001032663A3 (en) Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
GEP20064005B (en) Use of novel benzoimidazole derivatives as antiproliferative agents
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
NZ515705A (en) Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) alpha
DE60112330D1 (en) Pyrazolopyridinderivate
BRPI0610644B8 (en) compound and pharmaceutical composition comprising such compound and a pharmaceutically acceptable carrier or diluent.
MXPA05006889A (en) Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
IL157540A (en) Pharmaceutical compositions comprising n-(aryl)-2-arylethenesulfonamides, some such novel compounds and process for their preparation
EP1019047A4 (en) Antithrombotic agents
HUP0203847A3 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants, process for their preparation and pharmaceutical compositions containing them
HUP0301784A3 (en) Biphenyl derivatives, of imidazole and benzimidazole the use thereof, process for the preparation of compounds and pharmaceutical compositions containing them
DE60023154D1 (en) ALKOXY-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, MEDICAMENTS CONTAINING THEM AND THEIR USE
ECSP993250A (en) POLYMORPHES OF TELMISARTAN, PROCEDURE FOR ITS PREPARATION AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
ATE293635T1 (en) STREPTOGRAMINE DERIVATIVES, THEIR PRODUCTION AND PREPARATIONS CONTAINING THEM
TR200100906T2 (en) Benzamide derivatives as thrombin inhibitors
MXPA03009723A (en) Processes and intermediates for preparing benzyl substituted epoxides.
DE50010009D1 (en) Hydroxamsäurederivate
AU7288900A (en) Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
ES2179668T3 (en) A WF002 COMPOUND, ITS PRODUCTION AND ITS USE.